Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2023-10-13 Regulatory Filings
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 13, 2023. It provides a Regulation FD Disclosure about the CMS 2024 Star Ratings update and its expected impact on CVS Health's revenues and business outlook. The document includes a press release as an exhibit and forward-looking statements caution. There are no detailed financial statements or comprehensive financial analysis included, only an update on a specific event affecting future revenues. This type of filing is a regulatory announcement of a material event rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2023-10-13 English
PRIMARY DOCUMENT
Director's Dealing
2023-10-02 English
PRIMARY DOCUMENT
Director's Dealing
2023-10-02 English
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 21, 2023, reporting the election of a new director, Michael F. Mahoney, to the Board of Directors of CVS Health Corporation. The content focuses on the appointment of a board member, detailing his background, qualifications, and independence status. There is no financial data, earnings information, or report publication mentioned. The key item is Item 5.02, which relates to changes in directors or officers. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 5289 characters, which is sufficient to contain substantive information about the board change rather than a brief announcement. Hence, the classification is MANG with high confidence.
2023-09-21 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by CVS Health Corporation. It includes a Regulation FD Disclosure about a senior management webcast reaffirming full year 2023 earnings guidance and cash flow guidance. The document contains detailed reconciliations of projected GAAP and non-GAAP earnings per share, forward-looking statements, and disclaimers. It does not contain full financial statements or comprehensive financial analysis typical of an Annual Report (10-K) or Interim Report (IR). Instead, it provides an update on financial guidance and management commentary. The presence of a webcast presentation and reaffirmation of guidance aligns with a Capital/Financing Update or Earnings Release. However, since it is a Form 8-K with a Regulation FD Disclosure primarily about reaffirming earnings guidance and includes detailed financial projections, it fits best under Earnings Release (ER). The document is substantive and over 10,000 characters, so it is not merely an announcement or report publication notice. Therefore, the classification is Earnings Release (ER).
2023-09-11 English
PRIMARY DOCUMENT
Director's Dealing
2023-09-08 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.